Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data

Caro, J. Jaime; Speckman, Jeanne L.; Salas, Maribel; Raggio, Gabriel; Jackson, Joseph D.
January 1999
CMAJ: Canadian Medical Association Journal;1/12/99, Vol. 160 Issue 1, p41
Academic Journal
Presents a medical study that examines the relation of persistence with treatment to the class of antihypertensive drug initially chosen. Methods; Results; Conclusions.


Related Articles

  • Compliance in hypertension: Why don't patients take their pills? Myers, Martin G. // CMAJ: Canadian Medical Association Journal;1/12/99, Vol. 160 Issue 1, p64 

    Discusses a Canadian Heart Health Survey on Canadians with hypertension and findings of poor compliance with long-term antihypertensive therapy. Factors that contribute to poor compliance; Results of another study on the behavior of patients taking medication for unstable angina; Factors...

  • Angiotensin II receptor blocker and diuretic combination for high BP.  // Modern Medicine;Jul95, Vol. 63 Issue 7, p39 

    Reports that losartan potassium/hydrochlorothiazide tablets have been approved by the US Food and Drug Administration (FDA) as safe for the management of hypertension. Dosage; Schedule; Other indications; Contraindications; Tests.

  • Extended-release calcium antagonist.  // Geriatrics;Jun96, Vol. 51 Issue 6, p18 

    Reports on the US Food and Drug Administration's approval of a new brand of extended-release diltiazem hydrogen chloride (Tiazac) for the treatment of hypertension. Mechanism of action; Recommended dosage.

  • WHAT TO WATCH OUT FOR WITH thiazides. Kirschenbaum, Harold L.; Rosenberg, Jack M. // RN;Jul83, Vol. 46 Issue 7, p28 

    Provides guidelines on administering thiazide diuretics for high blood pressure in patients with normal renal function. Mechanism of action of thiazide diuretics; Side effects of thiazide diuretics; Overview of interactions of thiazide with other drugs.

  • Aliskiren and Hydrochlorothiazide Tablets (Tektura®HCT). Elliott, William T.; Chan, James // Internal Medicine Alert;8/29/2008, Vol. 30 Issue 16, p126 

    The article reports that aliskiren is indicated for the treatment of hypertension, and is recommended for use as add-on-therapy by the U.S. Food and Drug Administration (FDA).

  • Reducing blood pressure in people of different ages. Staessen, Jen A.; Richart, Tom; Verdechia, Paolo // BMJ: British Medical Journal (International Edition);5/17/2008, Vol. 336 Issue 7653, p1080 

    The authors reflect on the use of hypotensive agents to reduce hypertension in patients and on research which has been done on them. They suggest that the benefits of the drugs increase with age and that they help manage overall cardiovascular risk. They argue that certain hypertension drugs may...

  • Aiming too high or too low? Searching for the appropriate therapeutic thresholds in hypertension is not over yet. Fedorowski, Artur // Evidence Based Medicine;Feb2015, Vol. 20 Issue 1, p27 

    In this article, the author comments on a study conducted by researcher C.J. Rodriguez and colleagues which focuses on the importance of identifying hypertensive patients who can benefit from pharmacological interventions. Topics discussed include increased arterial blood pressure as a risk...

  • New drug to treat pulmonary hypertension expected. Karpa, Kelly Dowhower // Drug Topics;3/18/2002, Vol. 146 Issue 6, pHSE10 

    Reports on the approval given to Actelion Ltd. and United Therapeutics Corp. for a drug to treat pulmonary arterial hypertension (PAH) by the U.S. Food and Drug Administration in November 2001. Discussion on the nature of PAH; Factors that contribute to pharmacist's inadequate knowledge about...

  • ACE inhibitor/calcium antagonist combination.  // Geriatrics;Mar97, Vol. 52 Issue 3, p17 

    Reports on the US Food and Drug Administration's (FDA) approval of Lexxel, a combination tablet with the angiotensin converting enzyme (ACE) inhibitor enalapril and calcium antagonist felodipine, for the maintenance treatment of hypertension. Results of clinical studies; Contraindication;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics